FDA approves AstraZeneca diabetes drug for treating heart failure risk

AstraZeneca's diabetes drug Farxiga has been approved for use in the United States as a treatment to reduce the chances of hospitalisation for heart failure in adults with type-2 diabetes and other cardiovascular risks, the British drugmaker said on Monday.

from Reuters: Health News https://ift.tt/32EsHb6
via IFTTT